par van Rijswijk, R;Jeziorski, K;Wagener, Theo;Van Laethem, Jean-Luc
;Reuse, Sophie
;Baron, Benoît;Wils, Jaques;EORTC GastroIntestinal Tract Cancer Cooperative Group,
Référence European journal of cancer, 40, 14, page (2077-2081)
Publication Publié, 2004-09
;Reuse, Sophie
;Baron, Benoît;Wils, Jaques;EORTC GastroIntestinal Tract Cancer Cooperative Group, Référence European journal of cancer, 40, 14, page (2077-2081)
Publication Publié, 2004-09
Article révisé par les pairs
| Titre: |
|
| Auteur: | van Rijswijk, R; Jeziorski, K; Wagener, Theo; Van Laethem, Jean-Luc; Reuse, Sophie; Baron, Benoît; Wils, Jaques; EORTC GastroIntestinal Tract Cancer Cooperative Group, |
| Informations sur la publication: | European journal of cancer, 40, 14, page (2077-2081) |
| Statut de publication: | Publié, 2004-09 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Fluorouracil |
| Leucovorin | |
| Pancreatic neoplasms/drug therapy | |
| MeSH keywords: | Adult |
| Aged | |
| Analgesics -- therapeutic use | |
| Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use | |
| Antimetabolites, Antineoplastic -- therapeutic use | |
| Disease-Free Survival | |
| Dose-Response Relationship, Drug | |
| Female | |
| Fluorouracil -- administration & dosage | |
| Humans | |
| Leucovorin -- administration & dosage | |
| Male | |
| Middle Aged | |
| Pancreatic Neoplasms -- drug therapy | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Journal Article | |
| Multicenter Study | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:doi/10.1016/j.ejca.2004.06.012 | |
| info:pii/S0959804904005027 | |
| info:scp/4444346409 | |
| info:pmid/15341982 |



